These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 864257)

  • 1. Kinetic studies on the fragmentation of the third component of complement (C3) by trypsin.
    Minta JO; Man D; Movat HZ
    J Immunol; 1977 Jun; 118(6):2192-8. PubMed ID: 864257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of soluble C3 fragments with guinea pig lymphocytes. Comparison of effects of C3a, C3b, C3c, and C3d on lymphokine production and lymphocyte proliferation.
    Koopman WJ; Sandberg AL; Wahl SM; Mergenhagen SE
    J Immunol; 1976 Jul; 117(1):331-6. PubMed ID: 932430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third component of complement (C3): structural properties in relation to functions.
    Bokisch VA; Dierich MP; Mūller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):1989-93. PubMed ID: 1056006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the breakdown of the third component of human complement (C3).
    Fontaine M; Rivat C
    Ann Immunol (Paris); 1979; 130C(3):349-66. PubMed ID: 475341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE; Harrison RA; Lachmann PJ
    J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase.
    Schwartz LB; Kawahara MS; Hugli TE; Vik D; Fearon DT; Austen KF
    J Immunol; 1983 Apr; 130(4):1891-5. PubMed ID: 6339618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-binding sites on C3 and C3b.
    Dierich MP; Bokisch VA
    J Immunol; 1977 Jun; 118(6):2145-50. PubMed ID: 864256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage of the complement system C3 component by HIV-1 proteinase.
    Kisselev AF; Mentele R; von der Helm K
    Biol Chem; 1997 May; 378(5):439-42. PubMed ID: 9191031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antigenic and molecular alterations of C3 in the fluid phase during an immune reaction in normal human serum. Demonstration of a new conversion product, C3x.
    Spitzer RE; Stitzel AE; Pauling VL; Davis NC; West CD
    J Exp Med; 1971 Sep; 134(3 Pt 1):656-80. PubMed ID: 15776568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiation of C3 cleavage in the alternative complement pathway.
    Fearon DT; Austen KF
    J Immunol; 1975 Nov; 115(5):1357-61. PubMed ID: 809512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the C3b receptor-binding domain in third component of complement.
    Becherer JD; Lambris JD
    J Biol Chem; 1988 Oct; 263(28):14586-91. PubMed ID: 2971659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of T lymphocyte functions by human C3 fragments. I. Inhibition of human T cell proliferative responses by a kallikrein cleavage fragment of human iC3b.
    Meuth JL; Morgan EL; DiSipio RG; Hugli TE
    J Immunol; 1983 Jun; 130(6):2605-11. PubMed ID: 6602172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement receptor binding of C3b-coated cells treated with C3b inactivator, beta 1H globulin and trypsin.
    Carlo JR; Ruddy S; Studer EJ; Conrad DH
    J Immunol; 1979 Aug; 123(2):523-8. PubMed ID: 88474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of tryptic fragments of human complement factor C3.
    Eggertsen G; Hellman U; Lundwall A; Folkersen J; Sjöquist J
    Mol Immunol; 1985 Aug; 22(8):833-41. PubMed ID: 3930949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of low-molecular-weight products following reaction of C3-C3b with C3b inactivator and with trypsin.
    Freedman J; Chaplin H; Johnson CA; Hughes-Jones NC
    Vox Sang; 1977 Oct; 33(4):212-20. PubMed ID: 70885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of the C3b-inactivator on the cell-bound C3b.
    Law SK; Fearon DT; Levine RP
    J Immunol; 1979 Mar; 122(3):759-65. PubMed ID: 448074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.
    Bokisch VA; Müller-Eberhard HJ; Cochrane CG
    J Exp Med; 1969 May; 129(5):1109-30. PubMed ID: 5778786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation and composition of the C3 activating enzyme complex of the properdin system. Sequential assembly of its components on solid-phase trypsin-agarose.
    Vogt W; Schmidt G; Dieminger L; Lynen R
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(5):440-55. PubMed ID: 126576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage of membrane bound C3bi, an intermediate of the third component of complement, to C3c and C3d-like fragments by crude leucocyte lysosomal lysates and purified leucocyte elastase.
    Carlo JR; Spitznagel JK; Studer EJ; Conrad DH; Ruddy S
    Immunology; 1981 Oct; 44(2):381-91. PubMed ID: 7028603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new cleavage site for elastase within the complement component 3.
    Claesson R; Kanasi E; Johansson A; Kalfas S
    APMIS; 2010 Oct; 118(10):765-8. PubMed ID: 20854470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.